Revenue from Contracts with Customers

6 Months Ended

Jun. 30, 2022

Revenue from Contract with Customer [Abstract]

Revenue from Contracts with Customers

3.   Revenue from Contracts with Customers. We recognize revenue when a customer obtains control of promised goods. The amount of revenue recognized reflects the consideration we expect to receive in exchange for these goods. Our revenue recognition policies have not changed from those disclosed in Note 1 to our consolidated financial statements in Item 8 of the 2021 Annual Report on Form 10-K.

Disaggregation of Revenue

Our revenue is disaggregated based on reporting segment, product category and geographical region. We design, develop, manufacture and market medical products for interventional and diagnostic procedures. For financial reporting purposes, we report our operations in two operating segments: cardiovascular and endoscopy. Our cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer (“OEM”). Within these product categories, we sell a variety of products, including cardiology and radiology devices (which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases), as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, and interventional oncology and spine devices. Our endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.

The following tables present revenue from contracts with customers by reporting segment, product category and geographical region for the three and six-month periods ended June 30, 2022 and 2021 (in thousands):

	Three Months Ended						Three Months Ended
	June 30, 2022						June 30, 2021
	United States		International		Total		United States		International		Total
Cardiovascular
Peripheral Intervention	$	65,795	$	45,160	$	110,955	$	63,235	$	42,365	$	105,600
Cardiac Intervention		33,909		55,665		89,574		33,217		52,436		85,653
Custom Procedural Solutions		27,318		21,775		49,093		27,392		21,244		48,636
OEM		30,048		7,000		37,048		27,420		4,983		32,403
Total		157,070		129,600		286,670		151,264		121,028		272,292
Endoscopy
Endoscopy Devices		7,604		702		8,306		7,507		526		8,033
Total	$	164,674	$	130,302	$	294,976	$	158,771	$	121,554	$	280,325

	Six Months Ended						Six Months Ended
	June 30, 2022						June 30, 2021
	United States		International		Total		United States		International		Total
Cardiovascular
Peripheral Intervention	$	127,895	$	88,833	$	216,728	$	120,101	$	78,413	$	198,514
Cardiac Intervention		62,458		108,603		171,061		62,468		97,922		160,390
Custom Procedural Solutions		53,873		41,482		95,355		52,284		41,773		94,057
OEM		57,844		12,618		70,462		50,310		10,027		60,337
Total		302,070		251,536		553,606		285,163		228,135		513,298
Endoscopy
Endoscopy Devices		15,596		1,189		16,785		14,980		960		15,940
Total	$	317,666	$	252,725	$	570,391	$	300,143	$	229,095	$	529,238